ABOUT THE
CONFERENCE
Uniting the global phage community to accelerate safe, effective and accessible therapies for patients facing AMR.
Founder’s Said
Our vision is simple but powerful: to connect the global phage community and turn phage innovations into practical, accessible therapies for patients with antibiotic-resistant infections.
Apply clinical experience to deliver patient-centered phage therapies
Promote international collaboration to drive practical solutions.
Combat antimicrobial resistance through science and patient-centered approaches.
Empower the worldwide phage community to create actionable solutions.
JAFRAL is the world’s biggest manufacturer of high-quality therapeutic phages, dedicated to expanding global access to phage therapy. We are committed to advancing education, fostering collaboration across the industry and supporting meaningful patient care. In line with this mission, we are proud to host this summit, bringing together clinicians, pharmacists, regulators and other stakeholders to drive the global advancement of phage therapy.
Unite pharma & biotech innovators, clinicians, regulators, pharmacists, scientists and industry leaders to strengthen and grow the global phage community.
Accelerate access to phage therapy for patients globally.
Support meaningful, patient-focused care by helping bring effective phage therapies closer to those who need them.
Build a better future for patients by combating AMR with phage therapies.
If you are engaged in the phage field, working to combat antimicrobial resistance (AMR), or addressing bacterial infections, this summit provides a unique platform for professionals from all backgrounds to connect, collaborate and exchange knowledge.
Pharmaceutical and biotech professionals exploring the future of phage therapy and innovative treatment solutions.
Doctors, clinicians and infectious disease specialists seeking practical insights and the latest developments in phage therapy.
Regulatory authorities and policymakers developing frameworks for safe, effective and accessible phage therapies.
Experts currently running clinical trials with phages.
Pharmacists involved in magistral phage formulations or interested in phage-based therapies.
Hospitals and healthcare organizations considering the integration of phage therapy into clinical practice.
Industry partners and suppliers supporting the infrastructure of phage therapy.
Translational researches or applied phage scientists.
Emerging professionals and students interested in phage science, AMR or infectious disease research, looking to expand their knowledge and professional network.
Institutions focused on education, awareness and global access to combat AMR.
From leading experts to those just beginning their journey in the phage field, the JAFRAL Phage Summit offers an exceptional opportunity to connect, collaborate, and contribute to a global effort aimed at improving patient outcomes and figting AMR.
